Key result
Intracellular retention of the poliovirus receptor (PVR) by human cytomegalovirus UL141 prevents p53 induction, allowing the virus to escape immune- and p53-mediated surveillance.
The study reveals a novel cell-intrinsic PVR-p53 pathway where cell surface receptor loss signals p53 induction, a mechanism exploited by HCMV for immune evasion.
Novel PVR-p53 pathway identified in animal models; leaves open relevance to human HCMV infection and cardiovascular disease.
Initially characterised for its role in maintaining genome integrity, p53 has emerged as a critical hub for coordinating cellular responses to diverse types of stress. Here we identify cell surface receptor loss as a signal for p53 induction. The poliovirus receptor (PVR) regulates angiogenesis, leucocyte adhesion and immune surveillance. We demonstrate that loss of PVR from endothelial cells also promotes cell cycle arrest through the induction of a p53 transcriptional programme. The p53 induction is post-translational and, despite remaining associated with MDM2, p53 exhibits reduced ubiquitination, aiding its stabilisation. Increased expression of PVR marks malignant or infected cells, and retention of PVR in the endoplasmic reticulum by human cytomegalovirus (HCMV) UL141 protein allows HCMV infected cells to evade immunity. We show that intracellular retention of PVR by UL141 prevents p53 induction, allowing HCMV to escape both the immune- and p53-mediated surveillance functions of PVR. These data reveal that p53 coordinates responses to changes in cell surface composition and that the cell intrinsic PVR-p53 pathway coupled with PVR-mediated immune surveillance functions provide a sensor mechanism to maintain expression of this multi-functional cell surface molecule.
No takes yet. Share an insight, caveat, or question.
Odell et al. (2022) studied Human cytomegalovirus (HCMV) infection. HCMV UL141 protein was evaluated on p53 induction and cell cycle arrest. Intracellular retention of the poliovirus receptor (PVR) by human cytomegalovirus UL141 prevents p53 induction, allowing the virus to escape immune- and p53-mediated surveillance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: